NCT06493955View on ClinicalTrials.gov

"Evaluation of the Effectiveness of Extending the Passerelle System for Prescribing Adapted Physical Activity to Patients With Type 2 Diabetes in Nouvelle-AQUItaine (France)"

NANot yet recruitingINTERVENTIONAL
Enrollment

308

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

Adapted physical activity for 12 months

6 additional months of adapted physical activity after the 6 first months

OTHER

Adapted physical activity for 6 months

standard 6-month prescription for adapted physical activity

Trial Locations (1)

Unknown

Cabinet Médical Bergerac, Bergerac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT06493955 - "Evaluation of the Effectiveness of Extending the Passerelle System for Prescribing Adapted Physical Activity to Patients With Type 2 Diabetes in Nouvelle-AQUItaine (France)" | Biotech Hunter | Biotech Hunter